J CARDIOVASC PHARM T 潤色咨詢

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

出版年份:1996 年文章數(shù):642 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Quarterly 自引率:2.8% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量40.74% (2022年為3.70%)
自引率
2.8 %
年文章數(shù)
642
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):11155)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):3708次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):945次)
期刊簡介
稿件收錄要求
Journal of Cardiovascular Pharmacology and Therapeutics?is a peer-reviewed journal that publishes original basic human studies, original animal studies, and original bench research with potential clinical application to cardiovascular pharmacology and therapeutics. The focus of the experimental studies is translational research. The journal also publishes review articles on basic research, clinical research, editorials, commentaries, points of view, and controversies. Selected journal supplements will also be published. Future focus will include cardioprotective therapies, stem cell therapy, regenerative cardiology, therapies for preventive cardiology (risk factor management), and antiarrhythmic therapies.? Selected journal supplements will also be published.

Every informative issue of?Journal of Cardiovascular Pharmacology and Therapeutics (JCPT)?offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year,?JCPT?examines and analyzes arenas such as:

    • Agents that Reduce Myocardial Infarct Size
    • Agents that Reduce Myocardial Remodeling
    • Angiotensin Converting Enzyme Inhibitors
    • Antihypertensive Therapy
    • Arrhythmias
    • Atrial Fibrillation
    • Beta-Blocker Therapies
    • Cardioembolic Stroke
    • Cardiomyopathy
    • Cardioprotective Agents
    • Cardiopulmonary Resuscitation
    • Cardiovascular Combination Therapies
    • Chronic Angina
    • Chronic Cardiac Ischemia
    • Congestive Heart Failure
    • Coronary Artery Disease
    • Coronary Revascularization
    • Heparin Therapies
    • Hypertension
    • Hypotension
    • Implantable Devices
    • Ischemic Heart Disease
    • Myocardial Infarction
    • Percutaneous Coronary Interventions
    • Peripheral Arterial Disease
    • Preconditioning/Postconditioning
    • Regenerative Cardiology
    • Stem Cell Therapy